Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
06978 IMMUNOTECH-B
RT Nominal unchange1.950 0.000 (0.000%)
Latest  |  Final  |  Interim
Non-current Assets
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others474,253-5.293%500,759527,251426,588154,492
Land & other Lease Assets0--0000
Intangible Assets21,410-48.880%41,88242,48614,2507,371
Interests in Asso. & JCEs0--0000
Other Non-current Assets43,226-51.837%89,749191,586244,651164,643

538,889-14.785%632,390761,323685,489326,506
Current Assets
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Inventories0--0000
Trade Receivables0--0000
Cash & Bank Balances79,64552.691%52,16158,448353,341845,386
Other Current Assets101,185-37.437%161,73359,66658,85938,337
Assets Held for Sale0--0000

180,830-15.458%213,894118,114412,200883,723
Current Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Trade Payables55,05717.744%46,76037,39432,1525,840
S-T Debt & Leases26,2886.520%24,67926,05620,2097,204
Other Current Liabilities396,861200.659%131,997145,024127,74018,573
Liab asso w/ Assets Held for Sale0--0000

478,206135.065%203,436208,474180,10131,617
Net Current Assets(297,376)--10,458(90,360)232,099852,106
Total Assets Less Current Liabilities241,513-62.431%642,848670,963917,5881,178,612
Non-current Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
L-T Debt & Leases97,220-77.521%432,494123,75090,84543,856
Other Non-current Liabilities65,95967.137%39,46440,8443,5645,908

163,179-65.425%471,958164,59494,40949,764
Capital and Reserves
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
  Share Capital3,5760.000%3,5763,5763,5763,576
  Reserves77,525-54.408%170,040504,859818,6831,123,961
  Others0--0000
Shareholders' Funds81,101-53.287%173,616508,435822,2591,127,537
Non-controlling Interests(2,767)1.504%(2,726)(2,066)9201,311
Others0--0000

78,334-54.161%170,890506,369823,1791,128,848
Commitments and Contingent Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Commitments----573,993591,276653,73437,516
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 01/11/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB -92,515,000
%Change-21.673%
EPS / (LPS)RMB -0.180
NBV Per Share (¥)RMB 0.158
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.